Ro 50-3821
Term · Oncology and biomedicine · MLC-T-ONC-007482
A substance that is being studied in the treatment of anemia in patients who are receiving chemotherapy. It is a form of erythropoietin (a substance produced in the kidneys that stimulates the production of red blood cells) that has been changed in the laboratory. Also called methoxypolyethylene glycol epoetin beta.
| Identifier | MLC-T-ONC-007482 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | methoxypolyethylene glycol epoetin beta |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-007482",
"term": "Ro 50-3821",
"field": "Oncology and biomedicine",
"definition": "A substance that is being studied in the treatment of anemia in patients who are receiving chemotherapy. It is a form of erythropoietin (a substance produced in the kidneys that stimulates the production of red blood cells) that has been changed in the laboratory. Also called methoxypolyethylene glycol epoetin beta.",
"synonyms": [
"methoxypolyethylene glycol epoetin beta"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/ro-50-3821/"
}
Record 14,543 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.